Industry Research Reports
Home > Reports > Medical Devices & Consumables > Drug Eluting Coronary Stent System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Drug Eluting Coronary Stent System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 122 Pages
Report ld: 4619042
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Drug Eluting Coronary Stent System Market Size(US$)
CAGR 2025-2031
4.3%
Market Size,2031
USD 7,948
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 6,191 million
Market Forecast in 2031(Value)
US$ 7,948 million
CAGR
4.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Drug Eluting Coronary Stent System was estimated to be worth US$ 5963 million in 2024 and is forecast to a readjusted size of US$ 7948 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects.
North American market for Drug Eluting Coronary Stent System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Eluting Coronary Stent System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Drug Eluting Coronary Stent System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Drug Eluting Coronary Stent System include Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Coronary Stent System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drug Eluting Coronary Stent System by region & country, by Type, and by Application.
The Drug Eluting Coronary Stent System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Coronary Stent System.
MARKET SEGMENTATION
By Company
- Boston Scientific
- Medtronic
- Abbott
- B.Braun
- BD
- Biotronik AG
- Stentys SA
- Sino Medical
- Beijing ESSEN Technology
- Beijing Advanced Medical Technologies
- LifeTech Scientific Corporation
- MicroPort Scientific Corporation
- Yilson Medical Technology
- Lepu Medical Technology
- Shandong Hua'an Biotechnology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Rapamycin Eluting Stent
- Everolimus Eluting Stent
- Others
Segment by Application
- Hospitals
- Clinic
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Eluting Coronary Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Drug Eluting Coronary Stent System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Drug Eluting Coronary Stent System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Drug Eluting Coronary Stent System Product Introduction
1.2 Global Drug Eluting Coronary Stent System Market Size Forecast
1.2.1 Global Drug Eluting Coronary Stent System Sales Value (2020-2031)
1.2.2 Global Drug Eluting Coronary Stent System Sales Volume (2020-2031)
1.2.3 Global Drug Eluting Coronary Stent System Sales Price (2020-2031)
1.3 Drug Eluting Coronary Stent System Market Trends & Drivers
1.3.1 Drug Eluting Coronary Stent System Industry Trends
1.3.2 Drug Eluting Coronary Stent System Market Drivers & Opportunity
1.3.3 Drug Eluting Coronary Stent System Market Challenges
1.3.4 Drug Eluting Coronary Stent System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Eluting Coronary Stent System Players Revenue Ranking (2024)
2.2 Global Drug Eluting Coronary Stent System Revenue by Company (2020-2025)
2.3 Global Drug Eluting Coronary Stent System Players Sales Volume Ranking (2024)
2.4 Global Drug Eluting Coronary Stent System Sales Volume by Company Players (2020-2025)
2.5 Global Drug Eluting Coronary Stent System Average Price by Company (2020-2025)
2.6 Key Manufacturers Drug Eluting Coronary Stent System Manufacturing Base and Headquarters
2.7 Key Manufacturers Drug Eluting Coronary Stent System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Drug Eluting Coronary Stent System
2.9 Drug Eluting Coronary Stent System Market Competitive Analysis
2.9.1 Drug Eluting Coronary Stent System Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Drug Eluting Coronary Stent System Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Coronary Stent System as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rapamycin Eluting Stent
3.1.2 Everolimus Eluting Stent
3.1.3 Others
3.2 Global Drug Eluting Coronary Stent System Sales Value by Type
3.2.1 Global Drug Eluting Coronary Stent System Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Drug Eluting Coronary Stent System Sales Value, by Type (2020-2031)
3.2.3 Global Drug Eluting Coronary Stent System Sales Value, by Type (%) (2020-2031)
3.3 Global Drug Eluting Coronary Stent System Sales Volume by Type
3.3.1 Global Drug Eluting Coronary Stent System Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Drug Eluting Coronary Stent System Sales Volume, by Type (2020-2031)
3.3.3 Global Drug Eluting Coronary Stent System Sales Volume, by Type (%) (2020-2031)
3.4 Global Drug Eluting Coronary Stent System Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinic
4.1.3 Others
4.2 Global Drug Eluting Coronary Stent System Sales Value by Application
4.2.1 Global Drug Eluting Coronary Stent System Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Drug Eluting Coronary Stent System Sales Value, by Application (2020-2031)
4.2.3 Global Drug Eluting Coronary Stent System Sales Value, by Application (%) (2020-2031)
4.3 Global Drug Eluting Coronary Stent System Sales Volume by Application
4.3.1 Global Drug Eluting Coronary Stent System Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Drug Eluting Coronary Stent System Sales Volume, by Application (2020-2031)
4.3.3 Global Drug Eluting Coronary Stent System Sales Volume, by Application (%) (2020-2031)
4.4 Global Drug Eluting Coronary Stent System Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Drug Eluting Coronary Stent System Sales Value by Region
5.1.1 Global Drug Eluting Coronary Stent System Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Drug Eluting Coronary Stent System Sales Value by Region (2020-2025)
5.1.3 Global Drug Eluting Coronary Stent System Sales Value by Region (2026-2031)
5.1.4 Global Drug Eluting Coronary Stent System Sales Value by Region (%), (2020-2031)
5.2 Global Drug Eluting Coronary Stent System Sales Volume by Region
5.2.1 Global Drug Eluting Coronary Stent System Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Drug Eluting Coronary Stent System Sales Volume by Region (2020-2025)
5.2.3 Global Drug Eluting Coronary Stent System Sales Volume by Region (2026-2031)
5.2.4 Global Drug Eluting Coronary Stent System Sales Volume by Region (%), (2020-2031)
5.3 Global Drug Eluting Coronary Stent System Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Drug Eluting Coronary Stent System Sales Value, 2020-2031
5.4.2 North America Drug Eluting Coronary Stent System Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Drug Eluting Coronary Stent System Sales Value, 2020-2031
5.5.2 Europe Drug Eluting Coronary Stent System Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Drug Eluting Coronary Stent System Sales Value, 2020-2031
5.6.2 Asia Pacific Drug Eluting Coronary Stent System Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Drug Eluting Coronary Stent System Sales Value, 2020-2031
5.7.2 South America Drug Eluting Coronary Stent System Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Drug Eluting Coronary Stent System Sales Value, 2020-2031
5.8.2 Middle East & Africa Drug Eluting Coronary Stent System Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Eluting Coronary Stent System Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Drug Eluting Coronary Stent System Sales Value and Sales Volume
6.2.1 Key Countries/Regions Drug Eluting Coronary Stent System Sales Value, 2020-2031
6.2.2 Key Countries/Regions Drug Eluting Coronary Stent System Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Drug Eluting Coronary Stent System Sales Value, 2020-2031
6.3.2 United States Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Drug Eluting Coronary Stent System Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Drug Eluting Coronary Stent System Sales Value, 2020-2031
6.4.2 Europe Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Drug Eluting Coronary Stent System Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Drug Eluting Coronary Stent System Sales Value, 2020-2031
6.5.2 China Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
6.5.3 China Drug Eluting Coronary Stent System Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Drug Eluting Coronary Stent System Sales Value, 2020-2031
6.6.2 Japan Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Drug Eluting Coronary Stent System Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Drug Eluting Coronary Stent System Sales Value, 2020-2031
6.7.2 South Korea Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Drug Eluting Coronary Stent System Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Eluting Coronary Stent System Sales Value, 2020-2031
6.8.2 Southeast Asia Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Drug Eluting Coronary Stent System Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Drug Eluting Coronary Stent System Sales Value, 2020-2031
6.9.2 India Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
6.9.3 India Drug Eluting Coronary Stent System Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Boston Scientific Drug Eluting Coronary Stent System Product Offerings
7.1.5 Boston Scientific Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Medtronic Drug Eluting Coronary Stent System Product Offerings
7.2.5 Medtronic Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Abbott Drug Eluting Coronary Stent System Product Offerings
7.3.5 Abbott Recent Development
7.4 B.Braun
7.4.1 B.Braun Company Information
7.4.2 B.Braun Introduction and Business Overview
7.4.3 B.Braun Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 B.Braun Drug Eluting Coronary Stent System Product Offerings
7.4.5 B.Braun Recent Development
7.5 BD
7.5.1 BD Company Information
7.5.2 BD Introduction and Business Overview
7.5.3 BD Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 BD Drug Eluting Coronary Stent System Product Offerings
7.5.5 BD Recent Development
7.6 Biotronik AG
7.6.1 Biotronik AG Company Information
7.6.2 Biotronik AG Introduction and Business Overview
7.6.3 Biotronik AG Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Biotronik AG Drug Eluting Coronary Stent System Product Offerings
7.6.5 Biotronik AG Recent Development
7.7 Stentys SA
7.7.1 Stentys SA Company Information
7.7.2 Stentys SA Introduction and Business Overview
7.7.3 Stentys SA Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Stentys SA Drug Eluting Coronary Stent System Product Offerings
7.7.5 Stentys SA Recent Development
7.8 Sino Medical
7.8.1 Sino Medical Company Information
7.8.2 Sino Medical Introduction and Business Overview
7.8.3 Sino Medical Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sino Medical Drug Eluting Coronary Stent System Product Offerings
7.8.5 Sino Medical Recent Development
7.9 Beijing ESSEN Technology
7.9.1 Beijing ESSEN Technology Company Information
7.9.2 Beijing ESSEN Technology Introduction and Business Overview
7.9.3 Beijing ESSEN Technology Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Beijing ESSEN Technology Drug Eluting Coronary Stent System Product Offerings
7.9.5 Beijing ESSEN Technology Recent Development
7.10 Beijing Advanced Medical Technologies
7.10.1 Beijing Advanced Medical Technologies Company Information
7.10.2 Beijing Advanced Medical Technologies Introduction and Business Overview
7.10.3 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Product Offerings
7.10.5 Beijing Advanced Medical Technologies Recent Development
7.11 LifeTech Scientific Corporation
7.11.1 LifeTech Scientific Corporation Company Information
7.11.2 LifeTech Scientific Corporation Introduction and Business Overview
7.11.3 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Product Offerings
7.11.5 LifeTech Scientific Corporation Recent Development
7.12 MicroPort Scientific Corporation
7.12.1 MicroPort Scientific Corporation Company Information
7.12.2 MicroPort Scientific Corporation Introduction and Business Overview
7.12.3 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Product Offerings
7.12.5 MicroPort Scientific Corporation Recent Development
7.13 Yilson Medical Technology
7.13.1 Yilson Medical Technology Company Information
7.13.2 Yilson Medical Technology Introduction and Business Overview
7.13.3 Yilson Medical Technology Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Yilson Medical Technology Drug Eluting Coronary Stent System Product Offerings
7.13.5 Yilson Medical Technology Recent Development
7.14 Lepu Medical Technology
7.14.1 Lepu Medical Technology Company Information
7.14.2 Lepu Medical Technology Introduction and Business Overview
7.14.3 Lepu Medical Technology Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Lepu Medical Technology Drug Eluting Coronary Stent System Product Offerings
7.14.5 Lepu Medical Technology Recent Development
7.15 Shandong Hua'an Biotechnology
7.15.1 Shandong Hua'an Biotechnology Company Information
7.15.2 Shandong Hua'an Biotechnology Introduction and Business Overview
7.15.3 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Product Offerings
7.15.5 Shandong Hua'an Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Drug Eluting Coronary Stent System Industrial Chain
8.2 Drug Eluting Coronary Stent System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Eluting Coronary Stent System Sales Model
8.5.2 Sales Channel
8.5.3 Drug Eluting Coronary Stent System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Drug Eluting Coronary Stent System Market Trends
Table 2. Drug Eluting Coronary Stent System Market Drivers & Opportunity
Table 3. Drug Eluting Coronary Stent System Market Challenges
Table 4. Drug Eluting Coronary Stent System Market Restraints
Table 5. Global Drug Eluting Coronary Stent System Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Drug Eluting Coronary Stent System Revenue Market Share by Company (2020-2025)
Table 7. Global Drug Eluting Coronary Stent System Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Drug Eluting Coronary Stent System Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Drug Eluting Coronary Stent System Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Drug Eluting Coronary Stent System Manufacturing Base and Headquarters
Table 11. Key Manufacturers Drug Eluting Coronary Stent System Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Drug Eluting Coronary Stent System
Table 13. Global Drug Eluting Coronary Stent System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Coronary Stent System as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Coronary Stent System Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Drug Eluting Coronary Stent System Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Drug Eluting Coronary Stent System Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Drug Eluting Coronary Stent System Sales Market Share in Value by Type (2020-2025)
Table 20. Global Drug Eluting Coronary Stent System Sales Market Share in Value by Type (2026-2031)
Table 21. Global Drug Eluting Coronary Stent System Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Drug Eluting Coronary Stent System Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Drug Eluting Coronary Stent System Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Drug Eluting Coronary Stent System Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Drug Eluting Coronary Stent System Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Drug Eluting Coronary Stent System Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Drug Eluting Coronary Stent System Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Drug Eluting Coronary Stent System Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Drug Eluting Coronary Stent System Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Drug Eluting Coronary Stent System Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Drug Eluting Coronary Stent System Sales Market Share in Value by Application (2020-2025)
Table 32. Global Drug Eluting Coronary Stent System Sales Market Share in Value by Application (2026-2031)
Table 33. Global Drug Eluting Coronary Stent System Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Drug Eluting Coronary Stent System Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Drug Eluting Coronary Stent System Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Drug Eluting Coronary Stent System Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Drug Eluting Coronary Stent System Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Drug Eluting Coronary Stent System Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Drug Eluting Coronary Stent System Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Drug Eluting Coronary Stent System Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Drug Eluting Coronary Stent System Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Drug Eluting Coronary Stent System Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Drug Eluting Coronary Stent System Sales Value by Region (2020-2025) & (%)
Table 44. Global Drug Eluting Coronary Stent System Sales Value by Region (2026-2031) & (%)
Table 45. Global Drug Eluting Coronary Stent System Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Drug Eluting Coronary Stent System Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Drug Eluting Coronary Stent System Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Drug Eluting Coronary Stent System Sales Volume by Region (2020-2025) & (%)
Table 49. Global Drug Eluting Coronary Stent System Sales Volume by Region (2026-2031) & (%)
Table 50. Global Drug Eluting Coronary Stent System Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Drug Eluting Coronary Stent System Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Drug Eluting Coronary Stent System Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Drug Eluting Coronary Stent System Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Drug Eluting Coronary Stent System Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Drug Eluting Coronary Stent System Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Drug Eluting Coronary Stent System Sales Volume, (2026-2031) & (K Units)
Table 57. Boston Scientific Company Information
Table 58. Boston Scientific Introduction and Business Overview
Table 59. Boston Scientific Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Boston Scientific Drug Eluting Coronary Stent System Product Offerings
Table 61. Boston Scientific Recent Development
Table 62. Medtronic Company Information
Table 63. Medtronic Introduction and Business Overview
Table 64. Medtronic Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Medtronic Drug Eluting Coronary Stent System Product Offerings
Table 66. Medtronic Recent Development
Table 67. Abbott Company Information
Table 68. Abbott Introduction and Business Overview
Table 69. Abbott Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Abbott Drug Eluting Coronary Stent System Product Offerings
Table 71. Abbott Recent Development
Table 72. B.Braun Company Information
Table 73. B.Braun Introduction and Business Overview
Table 74. B.Braun Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. B.Braun Drug Eluting Coronary Stent System Product Offerings
Table 76. B.Braun Recent Development
Table 77. BD Company Information
Table 78. BD Introduction and Business Overview
Table 79. BD Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. BD Drug Eluting Coronary Stent System Product Offerings
Table 81. BD Recent Development
Table 82. Biotronik AG Company Information
Table 83. Biotronik AG Introduction and Business Overview
Table 84. Biotronik AG Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Biotronik AG Drug Eluting Coronary Stent System Product Offerings
Table 86. Biotronik AG Recent Development
Table 87. Stentys SA Company Information
Table 88. Stentys SA Introduction and Business Overview
Table 89. Stentys SA Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Stentys SA Drug Eluting Coronary Stent System Product Offerings
Table 91. Stentys SA Recent Development
Table 92. Sino Medical Company Information
Table 93. Sino Medical Introduction and Business Overview
Table 94. Sino Medical Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Sino Medical Drug Eluting Coronary Stent System Product Offerings
Table 96. Sino Medical Recent Development
Table 97. Beijing ESSEN Technology Company Information
Table 98. Beijing ESSEN Technology Introduction and Business Overview
Table 99. Beijing ESSEN Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Beijing ESSEN Technology Drug Eluting Coronary Stent System Product Offerings
Table 101. Beijing ESSEN Technology Recent Development
Table 102. Beijing Advanced Medical Technologies Company Information
Table 103. Beijing Advanced Medical Technologies Introduction and Business Overview
Table 104. Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Product Offerings
Table 106. Beijing Advanced Medical Technologies Recent Development
Table 107. LifeTech Scientific Corporation Company Information
Table 108. LifeTech Scientific Corporation Introduction and Business Overview
Table 109. LifeTech Scientific Corporation Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. LifeTech Scientific Corporation Drug Eluting Coronary Stent System Product Offerings
Table 111. LifeTech Scientific Corporation Recent Development
Table 112. MicroPort Scientific Corporation Company Information
Table 113. MicroPort Scientific Corporation Introduction and Business Overview
Table 114. MicroPort Scientific Corporation Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. MicroPort Scientific Corporation Drug Eluting Coronary Stent System Product Offerings
Table 116. MicroPort Scientific Corporation Recent Development
Table 117. Yilson Medical Technology Company Information
Table 118. Yilson Medical Technology Introduction and Business Overview
Table 119. Yilson Medical Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Yilson Medical Technology Drug Eluting Coronary Stent System Product Offerings
Table 121. Yilson Medical Technology Recent Development
Table 122. Lepu Medical Technology Company Information
Table 123. Lepu Medical Technology Introduction and Business Overview
Table 124. Lepu Medical Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Lepu Medical Technology Drug Eluting Coronary Stent System Product Offerings
Table 126. Lepu Medical Technology Recent Development
Table 127. Shandong Hua'an Biotechnology Company Information
Table 128. Shandong Hua'an Biotechnology Introduction and Business Overview
Table 129. Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Product Offerings
Table 131. Shandong Hua'an Biotechnology Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Drug Eluting Coronary Stent System Downstream Customers
Table 135. Drug Eluting Coronary Stent System Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Eluting Coronary Stent System Product Picture
Figure 2. Global Drug Eluting Coronary Stent System Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Drug Eluting Coronary Stent System Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Drug Eluting Coronary Stent System Sales Volume (2020-2031) & (K Units)
Figure 5. Global Drug Eluting Coronary Stent System Sales Price (2020-2031) & (US$/Unit)
Figure 6. Drug Eluting Coronary Stent System Report Years Considered
Figure 7. Global Drug Eluting Coronary Stent System Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Drug Eluting Coronary Stent System Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug Eluting Coronary Stent System Revenue in 2024
Figure 10. Drug Eluting Coronary Stent System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Rapamycin Eluting Stent Picture
Figure 12. Everolimus Eluting Stent Picture
Figure 13. Others Picture
Figure 14. Global Drug Eluting Coronary Stent System Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Drug Eluting Coronary Stent System Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Drug Eluting Coronary Stent System Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 17. Global Drug Eluting Coronary Stent System Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Drug Eluting Coronary Stent System Price by Type (2020-2031) & (US$/Unit)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Clinic
Figure 21. Product Picture of Others
Figure 22. Global Drug Eluting Coronary Stent System Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Drug Eluting Coronary Stent System Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Drug Eluting Coronary Stent System Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Drug Eluting Coronary Stent System Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Drug Eluting Coronary Stent System Price by Application (2020-2031) & (US$/Unit)
Figure 27. North America Drug Eluting Coronary Stent System Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Drug Eluting Coronary Stent System Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Drug Eluting Coronary Stent System Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Drug Eluting Coronary Stent System Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Drug Eluting Coronary Stent System Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Drug Eluting Coronary Stent System Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Drug Eluting Coronary Stent System Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Drug Eluting Coronary Stent System Sales Volume (%), (2020-2031)
Figure 39. United States Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Drug Eluting Coronary Stent System Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Drug Eluting Coronary Stent System Sales Value by Application (%), 2024 VS 2031
Figure 45. China Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
Figure 47. China Drug Eluting Coronary Stent System Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Drug Eluting Coronary Stent System Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Drug Eluting Coronary Stent System Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Drug Eluting Coronary Stent System Sales Value by Application (%), 2024 VS 2031
Figure 57. India Drug Eluting Coronary Stent System Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Drug Eluting Coronary Stent System Sales Value by Type (%), 2024 VS 2031
Figure 59. India Drug Eluting Coronary Stent System Sales Value by Application (%), 2024 VS 2031
Figure 60. Drug Eluting Coronary Stent System Industrial Chain
Figure 61. Drug Eluting Coronary Stent System Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Drug Eluting Coronary Stent System in 2025?
The global market size of Drug Eluting Coronary Stent System in 2025 was 6191 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Drug Eluting Coronary Stent System in 2031?
What is the annual compound growth rate of the global Drug Eluting Coronary Stent System market size from 2025 to 2031?
Which companies rank high in the global Drug Eluting Coronary Stent System market?
Related Reports
Global Drug Eluting Coronary Stent System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Drug Eluting Coronary Stent System market is projected to grow from US$ 6191 million in 2025 to US$ 8252 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 166
USD 4900.00
(Single User License)
Global Drug Eluting Coronary Stent System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Drug Eluting Coronary Stent System market size was US$ 6191 million in 2025 and is forecast to reach a readjusted size of US$ 8252 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 93
USD 4250.00
(Single User License)
Global Drug Eluting Coronary Stent System Market Research Report 2026
The global Drug Eluting Coronary Stent System market was valued at US$ 6191 million in 2025 and is anticipated to reach US$ 8252 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 124
USD 2900.00
(Single User License)
Drug Eluting Coronary Stent System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Eluting Coronary Stent System was estimated to be worth US$ 6191 million in 2025 and is projected to reach US$ 8252 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 114
USD 3950.00
(Single User License)
Global Drug Eluting Coronary Stent System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Eluting Coronary Stent System market size was US$ 5963 million in 2024 and is forecast to a readjusted size of US$ 7948 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 99
USD 4250.00
(Single User License)
Global Drug Eluting Coronary Stent System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Eluting Coronary Stent System market is projected to grow from US$ 5963 million in 2024 to US$ 7948 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 152
USD 4900.00
(Single User License)
Global Drug Eluting Coronary Stent System Market Research Report 2025
The global market for Drug Eluting Coronary Stent System was valued at US$ 5963 million in the year 2024 and is projected to reach a revised size of US$ 7948 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
Global and United States Drug Eluting Coronary Stent System Market Report & Forecast 2024-2030
The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects.
Published Date: 2024-12-14
Pages: 127
USD 4350.00
(Single User License)
Global Drug Eluting Coronary Stent System Market Insights, Forecast to 2030
The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects.
Published Date: 2024-12-14
Pages: 162
USD 4900.00
(Single User License)
Drug Eluting Coronary Stent System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Drug Eluting Coronary Stent System was estimated to be worth US$ 5690 million in 2023 and is forecast to a readjusted size of US$ 7655 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Published Date: 2024-11-22
Pages: 114
USD 3950.00
(Single User License)
Global Drug Eluting Coronary Stent System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Drug Eluting Coronary Stent System market is projected to grow from US$ 6191 million in 2025 to US$ 8252 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 166
USD 4900.00 (Single User License)Global Drug Eluting Coronary Stent System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Drug Eluting Coronary Stent System market size was US$ 6191 million in 2025 and is forecast to reach a readjusted size of US$ 8252 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 93
USD 4250.00 (Single User License)Global Drug Eluting Coronary Stent System Market Research Report 2026
The global Drug Eluting Coronary Stent System market was valued at US$ 6191 million in 2025 and is anticipated to reach US$ 8252 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 124
USD 2900.00 (Single User License)Drug Eluting Coronary Stent System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Eluting Coronary Stent System was estimated to be worth US$ 6191 million in 2025 and is projected to reach US$ 8252 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 114
USD 3950.00 (Single User License)Global Drug Eluting Coronary Stent System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Eluting Coronary Stent System market size was US$ 5963 million in 2024 and is forecast to a readjusted size of US$ 7948 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 99
USD 4250.00 (Single User License)Global Drug Eluting Coronary Stent System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Eluting Coronary Stent System market is projected to grow from US$ 5963 million in 2024 to US$ 7948 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 152
USD 4900.00 (Single User License)Global Drug Eluting Coronary Stent System Market Research Report 2025
The global market for Drug Eluting Coronary Stent System was valued at US$ 5963 million in the year 2024 and is projected to reach a revised size of US$ 7948 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-03-10
Pages: 96
USD 2900.00 (Single User License)Global and United States Drug Eluting Coronary Stent System Market Report & Forecast 2024-2030
The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects.
Published: 2024-12-14
Pages: 127
USD 4350.00 (Single User License)Global Drug Eluting Coronary Stent System Market Insights, Forecast to 2030
The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects.
Published: 2024-12-14
Pages: 162
USD 4900.00 (Single User License)Drug Eluting Coronary Stent System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Drug Eluting Coronary Stent System was estimated to be worth US$ 5690 million in 2023 and is forecast to a readjusted size of US$ 7655 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Published: 2024-11-22
Pages: 114
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now